Bristol-Myers Squibb Company (1BMY)
MTA
Closed
Aug 24, 2026
Day's Range
57.0152 wk Range
36.67Overview - 1BMY - Bristol-Myers Squibb Company
Key Statistics
Valuation
Enterprise Value
129.44B
P/E (Trailing)
‪14.78‬
PEG Ratio
‪0.09‬
Price / Sales (TTM)
‪2.38‬
Price / Book
‪6.13‬
EV / EBITDA
‪7.98‬
Profitability
Gross Margin
‪71.27%‬
Profit Margin
‪18.87%‬
Operating Margin
‪34.41%‬
Return on Assets
‪10.71%‬
Return on Equity
‪46.59%‬
Ownership
Shares Outstanding
2.04B
Float
2.03B
Held by Insiders
‪0.09%‬
Held by Institutions
‪84.68%‬
Price stats
Beta
‪0.22‬
50-Day Avg
‪52.58‬
200-Day Avg
‪49.35‬
Dividends
Payout Ratio
‪55.29%‬
Frequency
Quarterly
Market Cap - 1BMY - Bristol-Myers Squibb Company
Peers - 1BMY - Bristol-Myers Squibb Company
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
Profile Summary - 1BMY - Bristol-Myers Squibb Company
About
Bristol-Myers Squibb Company is a global biopharmaceutical company headquartered in Princeton, New Jersey, and founded in 1933. It discovers, develops, licenses, manufactures, markets, distributes, and sells innovative medicines addressing serious diseases worldwide. The company offers a diverse portfolio including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
